HCCI’s original reports powered by #HCCIdata

Policymakers and clinician consortia have identified low value care, defined as health care services that provide negligible clinical benefit to the patient when provided, as one way to curb excessive and inefficient medical spending. A previous HCCI report found that 18% of people with employer-sponsored insurance in 2019 received at least one low-value service, which…

High and rising health care costs affect individuals, families, and businesses across the country, and they have for decades. Cost forces difficult choices between health care and other needs. The Health Care Cost Institute’s mission of using data and analytics to improve the US health care system recognizes that people are at the heart of health…

Biologic drugs treat a range of diseases such as cancer, diabetes, retinal diseases, Crohn’s disease and many other conditions. Despite accounting for use by just 2% of Americans, spending on biologics is a major driver of drug spending in the United States. Biologics often come with a hefty price tag; for example, the most commonly…

According to the most recent year of data available, an estimated 42% of adults have obesity and almost 20% of children are diagnosed with obesity. It is well documented that obesity prevalence and associated health care costs continue to rise. The Kaiser Family Foundation has estimated the average annual health spending for people enrolled in commercial insurance…